UPDATE: Leerink Swann Upgrades Array BioPharma (ARRY) to Outperform; Exciting Data Help Leverage to MEK Inhibitors

Go back to UPDATE: Leerink Swann Upgrades Array BioPharma (ARRY) to Outperform; Exciting Data Help Leverage to MEK Inhibitors
Array Biopharma, Inc. (NASDAQ: ARRY) Delayed: 4.69 -0.02 (0.42%)
Previous Close $4.71    52 Week High $7.27 
Open $4.75    52 Week Low $2.39 
Day High $4.80    P/E N/A 
Day Low $4.63    EPS $-0.61 
Volume 8,283,330       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 3,179,791       

NOVARTIS AG (NYSE: NVS) Delayed: 158.86 +2.62 (1.68%)
Previous Close $156.24    52 Week High $89.15 
Open $156.17    52 Week Low $69.84 
Day High $159.72    P/E N/A 
Day Low $156.10    EPS $0.00 
Volume 1,183,726